Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome

Thrombosis Research

Volumn 121, Issue 5, 2008, Pages 631-636

  Peled, Nir ^a,c   Kassirer, Micha ^b,c   Kramer, Mordechai R ^a,c   Rogowski, Ori ^b,c   Shlomi, Dekel ^a,c   Fox, Ben ^a,c   Berliner, Abraham S ^b,c   Shitrit, David ^a,c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cardiovascular; Nocturnal hypoxia; Sleep apnea

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

ADULT; AGED; CELL ADHESION; ERYTHROCYTE AGGREGATION; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE;

EID: 39749152858     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.07.010     Document Type: Article

References (48)

1. Young T., Pelta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230-1235
2. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health prospective. Am J Respir Crit Care Med 165 (2002) 1217-1239
3. Shahar E., Whitney C.W., Redling, Lee E.T., Newman A.B., Javier Nieto F., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 (2001) 19-25
4. Peker Y., Hedner J., Norum J., Kraiczi H., and Hedner J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166 (2002) 159-165
5. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 9464 (2005) 1046-1053
6. Yaggi K.H., Concato J., Kernan W.N., Lichtman J.H., Brass L.M., and Mohsenin V.A. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353 19 (2005) 2034-2041
7. Peled N., Greenberg A., Pillar G., Zinder O., Levi N., and Lavie P. Contributions of hypoxia and Respiratory Disturbance Index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome. Am J Hypertens 11 (1998) 1284-1289
8. Peled N., Abinader E.G., Pillar G., Sharif D., and Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effect of continuous positive air pressure treatment. J Am Coll Cardiol 34 (1999) 1744-1749
9. Shitrit D., Peled N., Shitrit A.B., Bendayan D., and Kramer M.R. An association between oxygen desaturation and D-dimer test in patients with obstructive sleep apnea. Thromb Haemost 94 (2005) 544-547
10. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., Wolk R., Kara T., Accurso V., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105 21 (2002) 2462-2464
11. Yokoe T., Minoguchi K., Matsuo H., Oda N., Minoguchi H., Yoshino G., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 8 (2003) 1129-1134
12. Lavie L., Kraiczi H., Hefetz A., Ghandour H., Perelman A., Hedner J., et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165 12 (2002) 1624-1628
13. Peled N., Shitrit D., Ben Dayan D., Peled E., and Kramer M.R. Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity. Respiration 74 1 (2007) 50-55
14. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7 1 (2003) 35-51
15. Samocha-Bonet D.S., Lichtenberg D., Tomer A., Deutsch V., Mardi T., Goldin Y., et al. Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low grade inflammation. Obes Res 11 (2003) 403-407
16. Rampling M.W., Whittingstall P., and Linderkamp O. The effects of fibrinogen and its plasmin degradation products on the rheology of erythrocyte suspensions. Clin Hemorheol 4 (1984) 533-543
17. Weng X., Roederer G.O., Beaulieu R., and Cloutier G. Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidemic and hyperlipidemic individuals. Thromb Haemost 80 (1998) 903-908
18. Rotstein R., Landau T., Twig A., Rubinstein A., Koffler M., Justo D., et al. The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the presence of low grade subclinical smoldering inflammation in individuals with atherosclerotic risk factors. Atherosclerosis 165 2 (2002) 343-351
19. Berliner S., Zeltser D., Rotstein R., Fusman R., and Shapira I. A leukocyte and erythrocyte adhesiveness/aggregation test to reveal the presence of smoldering inflammation and risk factors for atherosclerosis. Med Hypotheses 57 2 (2001) 207-209
20. Assayag E.B., Bornstein N., Shapira I., Mardi T., Goldin Y., Tolshinki T., et al. Inflammation sensitive proteins and erythrocyte aggregation in atherothrombosis. Int J Cardiol 98 2 (2005) 271-276
21. Fusman G., Mardi T., Justo D., Rozenblat M., Rotstein R., Zeltser D., et al. Red blood cell adhesiveness/aggregation, C-reactive protein, fibrinogen and erythrocyte sedimentation rate in healthy individuals and in those with atherosclerosis risk factors. Am J Cardiol 90 (2002) 561-563
22. Vaya A., Martinez M., Carmena R., and Aznar J. Red blood cell aggregation and primary hyperlipoproteinemia. Thromb Res 72 (1993) 119-126
23. 2+ content, and erythrocyte membrane dynamic properties. Microvasc Res 46 (1993) 401-405
24. Ravazian S.M., Del Pino M., Simon A., and Levenson J. Increase in erythrocyte disaggregation shear stress in hypertension. Hypertension 20 (1992) 247-252
25. Valensi P., Paries J., Maheo P., Gaudey F., and Attali J.R. Erythrocyte rheological changes in obese patients: influence of hyperinsulinism. Int J Obes Relat Metab Disord 20 (1996) 814-819
26. Rechtschaffen A., and Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects (1968), U.S. Government Printing Office, Washington, D.C. [NIH Publication No. 204]
27. Berliner S., Shapira I., Rogowski O., Sadees N., Rotstein R., Fusman R., et al. Combined leukocyte and erythrocyte aggregation in the peripheral venous blood during sepsis. A clue to the presence of commonly shared adhesive protein(s). Int J Clin Lab Res 30 (2000) 27-31
28. Fusman R., Zeltser D., Rotestein R., Chapman Y., Avitzour D., Shapira I., et al. INFLAMET: an image analyzer to display erythrocyte adhesiveness/aggregation. Eur J Int Med 11 (2000) 271-276
29. Gamzu R., Rotstein R., Fusman R., Zeltser D., Berliner A.S., and Kupferminc M.J. Increased erythrocyte adhesiveness and aggregation in peripheral venous blood of woman with pregnancy induced hypertension. Obstet Gynecol 98 (2001) 307-312
30. Berliner S., Ben-Ari R., Samocha-Bonet D., Abu-Abeid S., Schechner V., Beigel Y., et al. The degree of red blood cell aggregation on peripheral blood glass corresponds to inter erythrocyte cohesive forces in laminar flow. Thromb Res 114 (2004) 37-44
31. Gamzu R., Barshtein G., Tsipis F., Lessing J.B., Berliner A.S., Kupferminc M.J., et al. Pregnancy-induced hypertension is associated with elevation of aggregability of red blood cells. Clin Hemorheol Microcirc 27 (2002) 163-169
32. Maharshak N., Shapira I., Rotstein R., Serov J., Aharonov S., Mardi T., et al. The erythrocyte adhesiveness/aggregation test for the detection of an acute phase response and for the assessment of its intensity. Clin Lab Haematol 24 (2002) 205-210
33. Somers V.K., Dyken M.E., Clary M.P., and Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 (1995) 1897-1904
34. Narkiewicz K., van de Borne P.J., Pesek C.A., Dyken M.E., Montano N., and Somers V.K. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99 (1999) 1183-1189
35. Saarelainer S., Seppala E., Laasonen K., and Hasan J. Circulating endothelin-I in obstructive sleep apnoea. Endothelium 5 (1997) 115-118
36. Lavie L., Perelman A., and Lavie P. Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest 120 (2001) 900-908
37. Dyugovskaya L., Lavie P., and Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165 (2002) 934-939
38. Sanner B.M., Konermann M., Tepel M., Groetz J., Mummenhoff C., and Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 16 (2000) 648-652
39. Hui D.S., Ko F.W., Fok J.P., Chan M.C., Li T.S., Tomlinson B., et al. The effect of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 125 (2004) 1768-1775
40. Moore-Gillen J.C., Treacher D.F., Gaminara E.J., Pearson T.C., and Cameron I.R. Intermittent hypoxia in patients with unexplained polycythemia. Br Med J 293 (1986) 588-590
41. Carlson J.T., Hedner J., Fageberg B., Ejnell H., Magnusson B., and Fyhrquist F. Secondary polycythemia associated with nocturnal apnea - a relationship not mediated by erythropoietin?. J Intern Med 231 (1992) 381-387
42. Cahan C., Decker M.J., Arnold J.L., Washington L.H., Veldhuis J.D., Goldwasser E., et al. Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients. J Appl Physiol 72 (1992) 2112-2117
43. Schmidt W. Effects of intermittent exposure to high altitude on blood volume and erythropoietic activity. High Alt Med Biol 3 (2002) 167-176
44. Mckeon J., Saunders N.A., Murree-Allen K., Olson L.G., Gyulay S., Dickerson J., et al. Urinary uric acid: creatinine ratio, serum erythropoietin and blood 2,3-diphosphoglycerate in patients with obstructive sleep apnea. Am Rev Respir Dis 142 (1990) 8-13
45. Maillard D., Fleury B., Housset B., Laffont S., Chabolle J., and Derenne J.P. Decreased oxyhemoglobin affinity in patients with sleep apnea syndrome. Am Rev Respir Dis 143 (1991) 486-489
46. Dikmenoǧlu N., Çiftçi, İÝleri E., Güven S.F., Seringeç N., Aksoy Y., et al. Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome. Sleep Med 7 (2006) 255-261
47. Schmidt W., Spielvogel H., Eckardt K.U., Quintela A., and Peňaloza R. Effect of chronic hypoxia and exercise on plasma erythropoietin level in natives living permanently at high altitude. J Appl Physiol 74 (1993) 1874-1878
48. Chin K., Ohi M., Kita H., Noguchi T., Otsuka N., Tsuboi T., et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 153 (1996) 1972-1976